Hikma Pharmaceuticals PLC (HKMPF)

22.33 0.00 (0.00%) At close: 09:49AM EDT

Hikma Pharmaceuticals PLC

1 New Burlington Place
London W1S 2HR
United Kingdom
44 20 7399 2760
https://www.hikma.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 9,100

Key executives

Name	Title	Pay	Exercised	Year born
Engineer Said Samih Taleb Darwazah	Executive Chairman	2.8M	N/A	1957
Mr. Riad Ali Mishlawi	CEO & Director	1.1M	N/A	1964
Mr. Mazen Samih Taleb Darwazah	Executive Vice Chairman & President of MENA	2.3M	N/A	1958
Mr. Khalid Waleed Hosny Al Nabilsi	Chief Financial Officer	N/A	N/A	1972
Patricia Bousfield	Chief Information Officer	N/A	N/A	N/A
Mr. Guy Featherstone	Associate Director of Investor Relations	N/A	N/A	N/A
Mr. Samuel Park	General Counsel	N/A	N/A	N/A
Mr. Bassam Wael Rushdi Kanaan CFA, CPA	Executive Vice President of Corporate Development and M&A	N/A	N/A	1965
Mr. Hussein Omar Arkhagha	Chief People Officer	N/A	N/A	N/A
Ms. Susan Ringdal	Executive Vice President of Strategic Planning & Global Affairs	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Corporate governance

Hikma Pharmaceuticals PLC’s ISS governance QualityScore as of 1 April 2024 is 7. The pillar scores are Audit: 6; Board: 9; Shareholder rights: 7; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.